An investigator-sponsored paediatric trial of MOR-208 in combination with an immune cell transplantation for Acute-lymphoblastic-leukaemia
Latest Information Update: 14 Sep 2015
At a glance
- Drugs Tafasitamab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 08 Sep 2015 According to Morpho Sys media release, company is planning to start enrolment in the first half of 2016.
- 12 Mar 2015 New trial record